Clinical Trials Directory

Trials / Conditions / Recurrent Thyroid Cancer

Recurrent Thyroid Cancer

17 registered clinical trials studyying Recurrent Thyroid Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingUltrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
NCT06733766
Chinese PLA General Hospital—
RecruitingCombination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
NCT04892303
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1
CompletedInolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer
NCT02152137
Alliance for Clinical Trials in OncologyPhase 2
CompletedDabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer
NCT01723202
Bhavana KondaPhase 2
CompletedSorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liv
NCT01502410
National Cancer Institute (NCI)Phase 2
CompletedIodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer
NCT01413113
University of WashingtonPhase 1
CompletedSunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
NCT00519896
University of WashingtonPhase 2
CompletedPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck
NCT00470496
Roswell Park Cancer InstitutePhase 1
CompletedSuberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurr
NCT00134043
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
NCT00126568
National Cancer Institute (NCI)Phase 2
CompletedBortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Ther
NCT00104871
National Cancer Institute (NCI)Phase 2
CompletedTanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
NCT00118248
National Cancer Institute (NCI)Phase 2
CompletedRomidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radi
NCT00098813
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
NCT00095693
National Cancer Institute (NCI)Phase 2
CompletedDecitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unrespon
NCT00085293
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can
NCT00068497
National Cancer Institute (NCI)N/A
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1